Viral Hepatitis and Liver Care
Viral hepatitis claims a life every 30 seconds worldwide, even though it’s a preventable disease and curable in the case of hepatitis C. In Idaho, chronic liver disease and cirrhosis are the tenth leading cause of death, which translates to nearly 17 deaths per 100,000, or 351 deaths recorded in 2021.
Led by an interdisciplinary panel of experts in hepatology, pharmacology, and behavioral health, ECHO’s Viral Hepatitis and Liver Care program aims to reverse these trends by helping identify approaches and resources for advancing patient care.
Register here to receive email updates on new programming.
- Join the 2024 Quality Improvement (QI) Cohort to earn MOC Part IV (MDs/DOs) or AAPA Category 1 (PAs) credit. Register here to join the QI Cohort. More information is coming soon!
- Earn CME/CE credits for joining the live, virtual, 1-hour Community of Practice sessions. Submit patient cases in advance or bring your cases and questions during the live sessions to receive feedback and have an in-depth discussion with the specialist panel and those who join.
- Earn CME/CE credits for watching past session recordings using our CE platform, eeds, with topics that range from hepatitis C treatment to fatty liver disease considerations. Available January 2024.
Not looking for credit? Visit ECHO Idaho's YouTube channel to view previous session recordings for this series.
ECHO's Community of Practice: Viral Hepatitis and Liver Care sessions will start Jan. 17, 2024.
12:30 to 1:30 p.m. Mountain time, third Wednesdays
ECHO Idaho’s full series schedule is available here.
The target audience includes MDs, DOs, PAs, NPs, RNs, and PharmDs, but all clinicians are welcome.
Participation in ECHO Idaho is free.
Please register here for the ongoing sessions.
Once you register, you’ll receive convenient, day-of Zoom access directly to your inbox – join us as your schedule allows.
- No-Cost Accredited Continuing Education: ECHO Idaho offers free, accredited continuing education credits (CE). CE credit is available for participating in both the live and recorded sessions using our CE platform, eeds, for the Viral Hepatitis and Liver Care program.
- MOC Part IV (MDs/DOs) and AAPA Category 1 PI-CME (PAs) will be offered upon completion of additional activities that supplement each of the one-hour sessions. Register here to join the QI Cohort. More information is coming soon!
- To learn more about the University of Idaho, WWAMI’s continuing education accreditation, and how to claim CE, visit our CE webpage.
- Professional Development: Participants gain new skills and competencies for managing patients.
- Creating Community: Clinician teams can increase professional satisfaction and decrease isolation, thus creating a sense of community.
- Increased Patient Satisfaction: Patients can continue to work with their trusted clinician instead of traveling long distances to be seen by a specialist.
- Improved Quality of Care: Health care professionals who participate in ECHO increase their knowledge and self-efficacy.
ECHO Idaho is led by the University of Idaho and the WWAMI Medical Education Program.
This publication was made possible by HC260900 from CDC. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Department, CDC, University of Idaho, WWAMI Medical Education Program, nor Project ECHO Idaho. September 17, 2021.
Series Testimonial from a Nurse Practitioner
Ian Troesoyer, NP, began attending ECHO Idaho in 2019 to familiarize himself with buprenorphine treatment. Since then, he’s participated in our other series, including Viral Hepatitis and Liver Care. Here, he explains how ECHO gave him the confidence to treat his first hepatitis C patient.